Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Andrew D. Bowser

News

MCL: Event-free survival at 2 years bodes well

Author:
Andrew D. Bowser
Publish date: December 23, 2022

With current therapies, patients who achieve 24 months of event-free survival live almost as long as the general population.

  • Read More

News

CLL phase 3 study: Zanubrutinib bests ibrutinib

Author:
Andrew D. Bowser
Publish date: December 16, 2022

The second-generation Bruton’s tyrosine kinase inhibitor zanubrutinib outperformed ibrutinib in a phase 3 study.

  • Read More

News

Transplant provides no clear survival benefit in real-world MCL study

Author:
Andrew D. Bowser
Publish date: December 5, 2022

The findings apparently contradict the survival benefit seen in clinical trial data, authors said, but are consistent with other recent...

  • Read More

News

Blame MCL, not transplantation, for late effects?

Author:
Andrew D. Bowser
Publish date: November 18, 2022

In patients with mantle cell lymphoma, long-term complications appeared to be caused by the disease itself, not by intensive therapy.

  • Read More

News

Phase 3 trial yields better way to predict MCL outcomes

Author:
Andrew D. Bowser
Publish date: November 8, 2022

In a phase 3 trial of mantle cell lymphoma outcomes, repeated evaluations of minimal residual disease over time improved prognostic power.

  • Read More

News

Telemedicine helps SCD patients survive COVID, but more need access

Author:
Andrew D. Bowser
Publish date: December 16, 2021

The second COVID-19 wave brought zero deaths and fewer complicated hospitalizations at the largest U.S. adult sickle cell disease center, but care...

  • Read More

News

Mesothelioma trials: Moving toward improved survival

Author:
Andrew D. Bowser
Publish date: December 14, 2021

New and emerging therapeutic developments hold the promise of extending survival for select patients.

  • Read More

News

Genomic classifier is one piece of the ILD diagnosis puzzle

Author:
Andrew D. Bowser
Publish date: November 10, 2021

Genomic testing increases confidence and consensus, but can’t be used in a vacuum, speaker says.

  • Read More

News

Novel bronchoscopic interventions appear promising for patients with COPD

Author:
Andrew D. Bowser
Publish date: November 3, 2021

The latest bronchoscopic interventions under investigation could be a “breath of fresh air” for patients with...

  • Read More

News

Fungal infection can mimic lung cancer metastases

Author:
Andrew D. Bowser
Publish date: October 20, 2021

Investigations of concerning head lesions led to a suspicious chest mass, prompting an eventual correct...

  • Read More

News

Life-threatening paradoxical bronchospasm may escape recognition in patients with COPD or asthma

Author:
Andrew D. Bowser
Publish date: October 19, 2021

Greater recognition and more education is needed, according to an investigator who conducted a study of spirometry tests at a VA medical center....

  • Read More

News

Dupilumab-improved lung function lasts in children with moderate to severe asthma

Author:
Andrew D. Bowser
Publish date: October 18, 2021

Add-on treatment yielded significant improvements over 52 weeks in children with the type 2 phenotype, the most...

  • Read More

News

9-step ladder may kids with allergies return to eggs

Author:
Andrew D. Bowser
Publish date: October 13, 2021

Attempts to reintroduce egg into the child’s diet can start at the age of 12 months or 6 months from the last reaction.

  • Read More

News

Polyethylene glycol linked to rare allergic reactions seen with mRNA COVID-19 vaccines

Author:
Andrew D. Bowser
Publish date: September 28, 2021

In the mRNA COVID-19 vaccines, PEG serves to stabilize the lipid nanoparticles that help...

  • Read More

News

Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems

Author:
Andrew D. Bowser
Publish date: September 21, 2021

In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close